WallStreetZenWallStreetZen

NASDAQ: RDHL
Redhill Biopharma Ltd Stock

Open Broker Account
$0.49-0.03 (-5.77%)
Updated Sep 29, 2022
RDHL Price
$0.49
Fair Value Price
$1.04
Market Cap
$27.88M
52 Week Low
$0.47
52 Week High
$6.50
P/E
-0.26x
P/B
-5.32x
P/S
1.59x
PEG
N/A
Dividend Yield
N/A
Revenue
$83.42M
Earnings
-$92.02M
Gross Margin
43.4%
Operating Margin
-91.37%
Profit Margin
-110.3%
Debt to Equity
-32.86
Operating Cash Flow
-$57M
Beta
1.13
Next Earnings
Nov 28, 2022
Ex-Dividend
N/A
Next Dividend
N/A

RDHL Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RDHL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RDHL ($0.49) is undervalued by 52.94% relative to our estimate of its Fair Value price of $1.04 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
RDHL ($0.49) is significantly undervalued by 52.94% relative to our estimate of its Fair Value price of $1.04 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
RDHL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more RDHL due diligence checks available for Premium users.

Be the first to know about important RDHL news, forecast changes, insider trades & much more!

RDHL News

Valuation

RDHL fair value

Fair Value of RDHL stock based on Discounted Cash Flow (DCF)
Price
$0.49
Fair Value
$1.04
Undervalued by
52.75%
RDHL ($0.49) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
RDHL ($0.49) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
RDHL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

RDHL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.26x
Industry
20.52x
Market
27.81x

RDHL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-5.32x
Industry
1.7x

RDHL's financial health

Profit margin

Revenue
$18.2M
Net Income
-$17.1M
Profit Margin
-94%
RDHL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
RDHL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$167.0M
Liabilities
$172.3M
Debt to equity
-32.86
RDHL's short-term liabilities ($73.90M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RDHL's long-term liabilities ($98.39M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RDHL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RDHL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.2M
Investing
$8.5M
Financing
-$4.9M
RDHL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RDHL vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
RDHL$27.88M-6.87%-0.26x-5.32x
NLTX$27.04M-4.51%-0.57x0.23x
CLVR$25.98M-3.36%-0.40x0.31x
ACRX$31.23M-2.30%0.73x0.94x
HUGE$31.60M-2.26%-1.93x0.96x

Redhill Biopharma Stock FAQ

What is Redhill Biopharma's quote symbol?

NASDAQ: RDHL) Redhill Biopharma trades on the NASDAQ under the ticker symbol RDHL. Redhill Biopharma stock quotes can also be displayed as NASDAQ: RDHL.

If you're new to stock investing, here's how to buy Redhill Biopharma stock.

What is the 52 week high and low for Redhill Biopharma (NASDAQ: RDHL)?

(NASDAQ: RDHL) Redhill Biopharma's 52-week high was $6.50, and its 52-week low was $0.47. It is currently -92.49% from its 52-week high and 3.17% from its 52-week low.

How much is Redhill Biopharma stock worth today?

(NASDAQ: RDHL) Redhill Biopharma currently has 571,233,000 outstanding shares. With Redhill Biopharma stock trading at $0.49 per share, the total value of Redhill Biopharma stock (market capitalization) is $27.88M.

Redhill Biopharma stock was originally listed at a price of $11.10 in Jan 7, 2013. If you had invested in Redhill Biopharma stock at $11.10, your return over the last 9 years would have been -95.6%, for an annualized return of -29.33% (not including any dividends or dividend reinvestments).

How much is Redhill Biopharma's stock price per share?

(NASDAQ: RDHL) Redhill Biopharma stock price per share is $0.49 today (as of Sep 29, 2022).

What is Redhill Biopharma's Market Cap?

(NASDAQ: RDHL) Redhill Biopharma's market cap is $27.88M, as of Oct 1, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Redhill Biopharma's market cap is calculated by multiplying RDHL's current stock price of $0.49 by RDHL's total outstanding shares of 571,233,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.